1.Narcolepsy with Obstructive Sleep Apnea in a 4-Year-Old Korean Girl: A Case Report.
Soonhak KWON ; Kyungmi JANG ; Sukyung HWANG ; Minhyun CHO ; Hyeeun SEO
Journal of Korean Medical Science 2013;28(5):792-794
A 4-yr-old girl has exhibited severe snoring, restless sleep and increasing daytime sleepiness over the last 3 months. The physical examination showed that she was not obese but had kissing tonsils. Polysomnography demonstrated increased apnea-hypopnea index (AHI) of 5.2, and multiple sleep latency tests (MSLT) showed shortened mean sleep latency and one sleep-onset REM period (SOREMP). She was diagnosed with obstructive sleep apnea (OSA) and underwent tonsillectomy and adenoidectomy. After the surgery, her sleep became much calmer, but she was still sleepy. Another sleep test showed normal AHI of 0.2, the mean sleep latency of 8 min, and two SOREMPs. Diagnosis of OSA to be effectively treated by surgery and narcolepsy without cataplexy was confirmed. Since young children exhibiting both OSA and narcolepsy can fail to be diagnosed with the latter, it's desirable to conduct MSLT when they have severe daytime sleepiness or fail to get better even with good treatment.
Adenoidectomy
;
Asian Continental Ancestry Group
;
Child, Preschool
;
Disorders of Excessive Somnolence/diagnosis
;
Female
;
Humans
;
Methylphenidate/therapeutic use
;
Narcolepsy/complications/*diagnosis/surgery
;
Polysomnography
;
Republic of Korea
;
Sleep Apnea, Obstructive/*diagnosis/drug therapy/surgery
;
Tonsillectomy
2.Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial.
Heui Soo MOON ; Min Kyung CHU ; Jeong Wook PARK ; Kyungmi OH ; Jae Myun CHUNG ; Yong Jin CHO ; Eung Gyu KIM ; Jin Kuk DO ; Hyong Gi JUNG ; Sun Uck KWON
Journal of Clinical Neurology 2010;6(1):27-32
BACKGROUND AND PURPOSE: Frovatriptan is a selective 5-HT1B/1D agonist with a long duration of action and a low incidence of side effects. Although several placebo-controlled trials have documented the clinical efficacy and safety of frovatriptan in adults with migraine, this drug has not previously been studied in Asian including Korean patients. METHODS: In this double-blind multicenter trial, 229 patients with migraine were randomized to receive frovatriptan 2.5 mg or placebo upon the occurrence of a moderate-to-severe migraine. The primary outcome was the 2-hour headache response rate. RESULTS: Frovatriptan significantly increased the 2-hour headache response rate compared with placebo (52.9% vs. 34.0%, p=0.004). The headache response rates at 4, 6, and 12 hours were significantly higher in the frovatriptan group than in the placebo group, as was the pain-free rate at 2 hours (19.0% vs. 5.7%, p=0.004), 4 hours (40.7% vs. 23.0%, p=0.006), and 6 hours (56.1% vs. 34.0%, p=0.002). The median time to a headache response was significantly shorter in the frovatriptan group than in the placebo group (2.00 hours vs. 3.50 hours, p<0.001). The use of rescue medications was more common in the placebo group (p=0.005). Chest tightness associated with triptan was infrequent (2.5%), mild, and transient. CONCLUSIONS: These results demonstrate that 2.5-mg frovatriptan is effective and well tolerated in Korean migraineurs for acute treatment of migraine attacks.
Adult
;
Asian Continental Ancestry Group
;
Carbazoles
;
Headache
;
Humans
;
Incidence
;
Migraine Disorders
;
Oxalates
;
Thorax
;
Tryptamines
3.Transient Increase in Intrathoracic Pressure as a Contributing Factor to Cardioembolic Stroke.
Hung Youl SEOK ; Woo Keun SEO ; Mi Yeon EUN ; Do Young KWON ; Moon Ho PARK ; Kyungmi OH
Journal of Clinical Neurology 2010;6(4):212-215
BACKGROUND: The hemodynamic effects of increased intrathoracic pressure (ITP) have been the focus of many investigations. However, very little is known about the effects of elevated ITP on the occurrence of stroke. CASE REPORT: Four young patients with a cardioembolic source of stroke were examined. In all cases the stroke was preceded by an increase in ITP that occurred during coughing, vomiting, or sexual intercourse. CONCLUSIONS: We suggest that cardioembolic stroke is facilitated by situations in which ITP is elevated.
Cough
;
Embolism
;
Hemodynamics
;
Humans
;
Stroke
;
Vomiting
4.Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia
Nak-Hyun KIM ; Yunjung CHOI ; Kyungmi KWON ; Jeong Su PARK ; Kyoung Un PARK ; Song Mi MOON ; Kyoung-Ho SONG ; Eu Suk KIM ; Wan Beom PARK ; Hong Bin KIM
Journal of Korean Medical Science 2023;38(16):e129-
Background:
Alpha-toxin (AT), a major virulence factor of Staphylococcus aureus, is an important immunotherapeutic target to prevent or treat invasive S. aureus infections. Previous studies have suggested that anti-AT antibodies (Abs) may have a protective role against S. aureus bacteremia (SAB), but their function remains unclear. Therefore, we aimed to investigate the association between serum anti-AT Ab levels and clinical outcomes of SAB.
Methods:
Patients from a prospective SAB cohort at a tertiary-care medical center (n = 51) were enrolled in the study from July 2016 to January 2019. Patients without symptoms or signs of infection were enrolled as controls (n = 100). Blood samples were collected before the onset of SAB and at 2- and 4-weeks post-bacteremia. Anti-AT immunoglobin G (IgG) levels were measured using an enzyme-linked immunosorbent assay. All clinical S. aureus isolates were tested for the presence of hla using polymerase chain reaction.
Results:
Anti-AT IgG levels in patients with SAB before the onset of bacteremia did not differ significantly from those in non-infectious controls. Pre-bacteremic anti-AT IgG levels tended to be lower in patients with worse clinical outcomes (7-day mortality, persistent bacteremia, metastatic infection, septic shock), although the differences were not statistically significant. Patients who needed intensive care unit care had significantly lower anti-AT IgG levels at 2 weeks post-bacteremia (P = 0.020).
Conclusion
The study findings suggest that lower anti-AT Ab responses before and during SAB, reflective of immune dysfunction, are associated with more severe clinical presentations of infection.
5.In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection
Jeong Su PARK ; Yun Jung CHOI ; Kyungmi KWON ; Seong Jin CHOI ; Song Mi MOON ; Kyoung-Ho SONG ; Eu Suk KIM ; Kyoung Un PARK ; Hong Bin KIM
Annals of Laboratory Medicine 2023;43(4):389-391